Related Experiment Video
Updated: Sep 28, 2025

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
Published on: July 12, 2024
Large contribution of non-priority PAHs in atmospheric fine particles: Insights from time-resolved measurement and
Zhaojin An1, Xue Li1, Yi Yuan1
1State Key Joint Laboratory of Environmental Simulation and Pollution Control, School of Environment, Tsinghua University, Beijing 100084, China.
Abstract:
Polycyclic aromatic hydrocarbons (PAHs), detrimental to human health, are key components contributing to the carcinogenicity of fine particles. The 16 priority PAHs listed by the United States Environment Protection Agency have been studied extensively. However, other than them, there is a large diversity of PAH species, whose atmospheric concentrations, risks, and variations remain elusive. Here, we carried out a time-resolved nontarget measurement in atmospheric PM2.5 using an improved comprehensive two-dimensional gas chromatography mass spectrometry. The measurement conducted during a 5-day pollution episode at an urban site of Beijing with a time resolution of 2 h. The nontarget analysis of time-resolved chromatographic data was performed for screening PAHs. A total number of 85 PAHs were identified and quantified. We found that other than 16 EPA PAHs, other screened PAHs contributed 43.3% of the total PAH mass concentration and 40.8% poential health risks. Dynamic variations of mass concentrations and their potential health risks of the screened PAHs were captured during a short-term heavy pollution episode, during which the instantaneous PAHs concentrations were much higher than their average concentrations. This study shows the potential for application of nontarget analysis for online comprehensive two-dimensional gas chromatography mass spectrometry and highlights the importance of time-resolved measurement of PAHs in PM2.5 and attention on extended PAHs species other than 16 EPA PAHs.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

